David Lux
Family Medicine · Norfolk, NENPI 1174531651
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,020 and has fallen 64.3% since, to $364 in 2022.
Across 146 payments — averaging $13.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$329
- AstraZeneca$275
- GSK$246
- Amgen$224
- Novo Nordisk$158
- Amarin Pharma, Inc.$112
- plus $556 from 19 others
What the payments were for
- Food & beverage$1,899100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $329 |
| AstraZeneca | 19 | $275 |
| GSK | 26 | $246 |
| Amgen | 17 | $224 |
| Novo Nordisk | 12 | $158 |
| Amarin Pharma, Inc. | 8 | $112 |
| Pfizer | 6 | $81 |
| Lilly USA, LLC | 5 | $65 |
| E.r. Squibb & Sons, L.L.C. | 4 | $61 |
| Johnson & Johnson | 3 | $43 |
| Merck | 3 | $40 |
| Boehringer Ingelheim | 3 | $37 |
| Dexcom, Inc. | 3 | $37 |
| Biogen | 2 | $33 |
| Bioventus LLC | 1 | $22 |
| Biofire Diagnostics, LLC | 1 | $21 |
| Bayer | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Novartis | 1 | $14 |
| Astellas Pharma US Inc | 1 | $12 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Radius Health, Inc. | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
| Daiichi Sankyo Inc. | 1 | $11 |
How this compares
$1,899 in reported general payments places this provider in the 70th percentile of 981 family medicine providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisinopril | 51 | $406 |
| Tamsulosin Hcl | 21 | $382 |
| Atorvastatin Calcium | 36 | $338 |
| Omeprazole | 39 | $331 |
| Allopurinol | 18 | $258 |
| Simvastatin | 21 | $249 |
| Gabapentin | 11 | $194 |
| Losartan Potassium | 15 | $170 |
| Metoprolol Succinate | 17 | $142 |
| Rosuvastatin Calcium | 12 | $140 |
| Levothyroxine Sodium | 14 | $122 |
| Metformin Hcl | 16 | $122 |
| Amlodipine Besylate | 24 | $117 |
| Hydralazine Hcl | 16 | $116 |
| Hydrochlorothiazide | 13 | $65 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Norfolk
- Francisco DozonNorfolk$238K
- Michael IsraelLincoln$375K
- Randy KohlLincoln$67K
- James OmelGrand Island$67K
- Gerard StanleyOmaha$50K
- Jared KramerSt Paul$41K
- Randolph WaldmanHebron$27K
- Brian FinleyBellevue$20K
- William FitzgibbonsElkhorn$18K
- Michael BrennerSouth Sioux City$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.